OVID
Ovid Therapeutics Inc
NASDAQ: OVID · HEALTHCARE · BIOTECHNOLOGY
$2.69
-0.37% today
Updated 2026-04-29
Market cap
$465.47M
P/E ratio
—
P/S ratio
64.19x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$0 – $3
Volume
3.4M
Ovid Therapeutics Inc (OVID) Insider transactions
Net insider activity
Net buying (19,097,074 shares)
Buy transactions
89
Sell transactions
11
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-07 | PAPADOPOULOS, STELIOS | Director | Buy | 17,578 | $2.56 | $44999.68 |
| 2026-04-07 | FRIEDMAN, BART | Director | Buy | 8,789 | $2.56 | $22499.84 |
| 2026-04-07 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 17,578 | $2.56 | $44999.68 |
| 2026-03-23 | LEVIN, JEREMY M | Director, Executive Chairman | Sale | 47,333 | — | — |
| 2026-03-23 | LEVIN, JEREMY M | Director, Executive Chairman | Buy | 47,333 | $1.40 | $66266.20 |
| 2026-02-26 | RONA, JEFFREY A | CBFO | Buy | 408,750 | — | — |
| 2026-02-26 | RONA, JEFFREY A | CBFO | Buy | 68,125 | — | — |
| 2026-02-26 | PAPADOPOULOS, STELIOS | Director | Buy | 65,000 | — | — |
| 2026-02-26 | LEVIN, JEREMY M | Director | Buy | 957,000 | — | — |
| 2026-02-26 | FRIEDMAN, BART | Director | Buy | 65,000 | — | — |
| 2026-02-26 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 65,000 | — | — |
| 2026-02-26 | DUNCAN, BARBARA GAYLE | Director | Buy | 65,000 | — | — |
| 2026-02-26 | BERNSTEIN, KAREN | Director | Buy | 65,000 | — | — |
| 2026-02-26 | ALEXANDER, MARGARET A. | Director, President and CEO | Buy | 1,435,000 | — | — |
| 2026-02-23 | RONA, JEFFREY A | CBFO | Sale | 8,541 | $1.45 | $12384.45 |
| 2026-02-23 | ALEXANDER, MARGARET A. | Director, President and CEO | Sale | 11,656 | $1.45 | $16901.20 |
| 2026-01-04 | ALEXANDER, MARGARET A. | Director, President and CEO | Buy | 890,000 | — | — |
| 2025-12-15 | LEVIN, JEREMY M | Director, CEO | Sale | 71 | — | — |
| 2025-12-15 | LEVIN, JEREMY M | Director, CEO | Buy | 71,000 | — | — |
| 2025-12-11 | LEVIN, JEREMY M | Director, CEO | Buy | 35,500 | — | — |
| 2025-12-11 | LEVIN, JEREMY M | Director, CEO | Buy | 71 | — | — |
| 2025-12-11 | LEVIN, JEREMY M | Director, CEO | Buy | 47,333 | — | — |
| 2025-12-08 | TAKEDA, PHARMACEUTICAL CO LTD | 10% Owner | Sale | 1,250 | — | — |
| 2025-12-08 | TAKEDA, PHARMACEUTICAL CO LTD | 10% Owner | Buy | 1,250,000 | — | — |
| 2025-03-03 | PAPADOPOULOS, STELIOS | Director | Buy | 90,000 | — | — |
| 2025-02-26 | RONA, JEFFREY A | CBFO | Sale | 3,902 | $0.56 | $2185.12 |
| 2025-02-26 | ALEXANDER, MARGARET A. | President and COO | Sale | 5,279 | $0.56 | $2956.24 |
| 2025-02-20 | RONA, JEFFREY A | CBFO | Buy | 262,500 | — | — |
| 2025-02-20 | RONA, JEFFREY A | CBFO | Buy | 43,750 | — | — |
| 2025-02-20 | LEVIN, JEREMY M | Director, CEO | Buy | 1,650,000 | — | — |
| 2025-02-20 | FRIEDMAN, BART | Director | Buy | 45,000 | — | — |
| 2025-02-20 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 45,000 | — | — |
| 2025-02-20 | DUNCAN, BARBARA GAYLE | Director | Buy | 45,000 | — | — |
| 2025-02-20 | BERNSTEIN, KAREN | Director | Buy | 45,000 | — | — |
| 2025-02-20 | ALEXANDER, MARGARET A. | President and COO | Buy | 262,500 | — | — |
| 2025-02-20 | ALEXANDER, MARGARET A. | President and COO | Buy | 43,750 | — | — |
| 2025-01-27 | ALEXANDER, MARGARET A. | President and COO | Buy | 6,810 | $0.73 | $4971.30 |
| 2024-12-12 | FRIEDMAN, BART | Director | Buy | 90,000 | — | — |
| 2024-12-12 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 90,000 | — | — |
| 2024-12-12 | DUNCAN, BARBARA GAYLE | Director | Buy | 90,000 | — | — |
| 2024-12-12 | BERNSTEIN, KAREN | Director | Buy | 90,000 | — | — |
| 2024-09-09 | ALEXANDER, MARGARET A. | President and COO | Buy | 140,000 | — | — |
| 2024-07-30 | RONA, JEFFREY A | CBFO | Buy | 315,000 | — | — |
| 2024-03-18 | LEVIN, JEREMY M | Director, CEO | Buy | 18,248 | $2.76 | $50364.48 |
| 2024-02-22 | TARDIO, JASON | Chief Operating Officer | Buy | 168,750 | — | — |
| 2024-02-22 | TARDIO, JASON | Chief Operating Officer | Buy | 28,125 | — | — |
| 2024-02-22 | RONA, JEFFREY A | CBFO | Buy | 168,750 | — | — |
| 2024-02-22 | RONA, JEFFREY A | CBFO | Buy | 28,125 | — | — |
| 2024-02-22 | POOLE, ROBERT MICHAEL | Director | Buy | 30,000 | — | — |
| 2024-02-22 | PERONE, THOMAS MICHAEL | General Counsel, Secretary | Buy | 168,750 | — | — |
| 2024-02-22 | PERONE, THOMAS MICHAEL | General Counsel, Secretary | Buy | 28,125 | — | — |
| 2024-02-22 | LEVIN, JEREMY M | Director, CEO | Buy | 700,000 | — | — |
| 2024-02-22 | FRIEDMAN, BART | Director | Buy | 30,000 | — | — |
| 2024-02-22 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 30,000 | — | — |
| 2024-02-22 | DUNCAN, BARBARA GAYLE | Director | Buy | 30,000 | — | — |
| 2024-02-22 | BERNSTEIN, KAREN | Director | Buy | 30,000 | — | — |
| 2023-12-04 | LEVIN, JEREMY M | Director, CEO | Sale | 573,275 | — | — |
| 2023-02-23 | TARDIO, JASON | Chief Operating Officer | Buy | 175,000 | — | — |
| 2023-02-23 | RONA, JEFFREY A | CBFO | Buy | 175,000 | — | — |
| 2023-02-23 | POOLE, ROBERT MICHAEL | Director | Buy | 15,000 | — | — |
| 2023-02-23 | PERONE, THOMAS MICHAEL | General Counsel, Secretary | Buy | 175,000 | — | — |
| 2023-02-23 | LEVIN, JEREMY M | Director, CEO, 10% Owner | Buy | 600,000 | — | — |
| 2023-02-23 | FRIEDMAN, BART | Director | Buy | 15,000 | — | — |
| 2023-02-23 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 15,000 | — | — |
| 2023-02-23 | DUNCAN, BARBARA GAYLE | Director | Buy | 15,000 | — | — |
| 2023-02-23 | BERNSTEIN, KAREN | Director | Buy | 15,000 | — | — |
| 2022-09-12 | TARDIO, JASON | Chief Operating Officer | Sale | 17,344 | $2.15 | $37289.60 |
| 2022-07-01 | TAKEDA, PHARMACEUTICAL CO LTD | 10% Owner | Sale | 1,250 | — | — |
| 2022-07-01 | TAKEDA, PHARMACEUTICAL CO LTD | 10% Owner | Buy | 5,750,000 | — | — |
| 2022-04-08 | TARDIO, JASON | Chief Operating Officer | Buy | 87,498 | — | — |
| 2022-04-08 | TARDIO, JASON | Chief Operating Officer | Buy | 10,000 | — | — |
| 2022-04-08 | RONA, JEFFREY A | CBFO | Buy | 194,399 | — | — |
| 2022-04-08 | RONA, JEFFREY A | CBFO | Buy | 10,000 | — | — |
| 2022-04-08 | PERONE, THOMAS MICHAEL | General Counsel, Secretary | Buy | 25,399 | — | — |
| 2022-04-08 | PERONE, THOMAS MICHAEL | General Counsel, Secretary | Buy | 10,000 | — | — |
| 2022-04-08 | LEVIN, JEREMY M | Director, CEO, 10% Owner | Buy | 423,244 | — | — |
| 2022-04-08 | FRIEDMAN, BART | Director | Buy | 69,424 | — | — |
| 2022-04-08 | DUNCAN, BARBARA GAYLE | Director | Buy | 21,347 | — | — |
| 2022-04-08 | BERNSTEIN, KAREN | Director | Buy | 69,424 | — | — |
| 2022-02-03 | TARDIO, JASON | Chief Operating Officer | Buy | 175,000 | — | — |
| 2022-02-03 | RONA, JEFFREY A | CBFO | Buy | 218,750 | — | — |
| 2022-02-03 | POOLE, ROBERT MICHAEL | Director | Buy | 15,000 | — | — |
| 2022-02-03 | PERONE, THOMAS MICHAEL | General Counsel, Secretary | Buy | 175,000 | — | — |
| 2022-02-03 | LEVIN, JEREMY M | Director, CEO, 10% Owner | Buy | 600,000 | — | — |
| 2022-02-03 | FRIEDMAN, BART | Director | Buy | 15,000 | — | — |
| 2022-02-03 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 15,000 | — | — |
| 2022-02-03 | DUNCAN, BARBARA GAYLE | Director | Buy | 15,000 | — | — |
| 2022-02-03 | BERNSTEIN, KAREN | Director | Buy | 15,000 | — | — |
| 2021-10-06 | FITZGERALD, KEVIN JOSEPH | Director | Buy | 30,000 | — | — |
| 2021-07-14 | RAKHIT, AMIT | President and CMO | Buy | 34,017 | — | — |
| 2021-07-14 | RAKHIT, AMIT | President and CMO | Sale | 34,017 | $3.71 | $126203.07 |
| 2021-07-09 | POOLE, ROBERT MICHAEL | Director | Buy | 30,000 | — | — |
| 2021-07-01 | TARDIO, JASON | Chief Commercial Officer | Buy | 50,000 | — | — |
| 2021-06-11 | FRIEDMAN, BART | Director | Buy | 15,000 | — | — |
| 2021-06-11 | DUNCAN, BARBARA GAYLE | Director | Buy | 15,000 | — | — |
| 2021-06-11 | BERNSTEIN, KAREN | Director | Buy | 15,000 | — | — |
| 2021-06-02 | RONA, JEFFREY A | Chief Business Officer | Buy | 100,000 | — | — |
| 2021-05-17 | WILLIAMS, DOUGLAS E | Director | Buy | 1,750 | — | — |
| 2021-05-17 | FRIEDMAN, BART | Director | Buy | 1,750 | — | — |
| 2021-05-17 | DUNCAN, BARBARA GAYLE | Director | Buy | 1,750 | — | — |